Protalix BioTherapeutics, Inc.
PLX
$2.22
-$0.14-5.93%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 40.66M | 51.08M | 30.27M | 29.37M | 33.40M |
| Total Receivables | 16.50M | 2.94M | 9.47M | 14.43M | 9.44M |
| Inventory | 32.29M | 30.47M | 25.73M | 21.26M | 21.13M |
| Prepaid Expenses | -- | -- | 394.00K | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 2.77M | 1.86M | 803.00K | 1.45M | 1.51M |
| Total Current Assets | 92.22M | 86.36M | 66.67M | 66.50M | 65.49M |
|
|
|||||
| Total Current Assets | 92.22M | 86.36M | 66.67M | 66.50M | 65.49M |
| Net Property, Plant & Equipment | 13.64M | 12.95M | 12.58M | 12.53M | 9.74M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 4.47M | 3.03M | 3.09M | 3.23M | 3.26M |
| Total Assets | 110.34M | 102.34M | 82.35M | 82.26M | 78.49M |
|
|
|||||
| Total Accounts Payable | 6.51M | 4.29M | 5.26M | 5.38M | 6.69M |
| Total Accrued Expenses | 16.38M | 16.81M | 14.53M | 11.64M | 11.81M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.67M | 1.43M | 1.38M | 1.40M | 1.47M |
| Total Finance Division Other Current Liabilities | 6.84M | 4.86M | 5.35M | 3.54M | 4.12M |
| Total Other Current Liabilities | 6.84M | 4.86M | 5.35M | 3.54M | 4.12M |
| Total Current Liabilities | 31.39M | 27.39M | 26.52M | 21.95M | 24.09M |
|
|
|||||
| Total Current Liabilities | 31.39M | 27.39M | 26.52M | 21.95M | 24.09M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 7.54M | 7.05M | 6.94M | 6.78M | 3.88M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | 671.00K | 661.00K | 631.00K | 615.00K |
| Total Liabilities | 38.93M | 35.11M | 34.12M | 29.36M | 28.58M |
|
|
|||||
| Common Stock & APIC | 434.31M | 433.91M | 433.23M | 432.40M | 431.75M |
| Retained Earnings | -362.90M | -366.68M | -385.00M | -379.49M | -381.85M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 71.40M | 67.23M | 48.23M | 52.91M | 49.90M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 71.40M | 67.23M | 48.23M | 52.91M | 49.90M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 71.40M | 67.23M | 48.23M | 52.91M | 49.90M |
|
|
|||||